Devchand Paul

2.4k total citations
34 papers, 1.0k citations indexed

About

Devchand Paul is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Devchand Paul has authored 34 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Oncology, 14 papers in Cancer Research and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Devchand Paul's work include Breast Cancer Treatment Studies (14 papers), Cancer Treatment and Pharmacology (13 papers) and HER2/EGFR in Cancer Research (13 papers). Devchand Paul is often cited by papers focused on Breast Cancer Treatment Studies (14 papers), Cancer Treatment and Pharmacology (13 papers) and HER2/EGFR in Cancer Research (13 papers). Devchand Paul collaborates with scholars based in United States, United Kingdom and Germany. Devchand Paul's co-authors include Silvana Spadafora, Michelle Fan, Rowan T. Chlebowski, Georgiana K. Ellis, Henry G. Bone, J. W. G. Smith, Susie Jun, Scot Sedlacek, Svetislava J. Vukelja and Nicholas J. Robert and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.

In The Last Decade

Devchand Paul

34 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Devchand Paul United States	16	819	285	264	224	203	34	1.0k
R. Tarabuzzi Italy	18	459 0.6×	239 0.8×	163 0.6×	130 0.6×	810 4.0×	42	1.2k
Jochen Fleckenstein Germany	18	313 0.4×	268 0.9×	180 0.7×	47 0.2×	494 2.4×	43	1.3k
Afonso Ribeiro United States	20	664 0.8×	139 0.5×	126 0.5×	32 0.1×	517 2.5×	49	1.3k
Takashi Hatano Japan	13	253 0.3×	181 0.6×	39 0.1×	85 0.4×	244 1.2×	82	612
Friederike Koerber Germany	15	140 0.2×	373 1.3×	99 0.4×	72 0.3×	159 0.8×	31	1.1k
Jee Ye Kim South Korea	20	506 0.6×	177 0.6×	501 1.9×	13 0.1×	144 0.7×	109	1.3k
Hanne Melgaard Nielsen Denmark	18	687 0.8×	113 0.4×	1.5k 5.6×	75 0.3×	275 1.4×	32	1.9k
Amy Kupic United States	3	603 0.7×	197 0.7×	62 0.2×	337 1.5×	347 1.7×	5	798
Narciso Hernández Toriz Mexico	4	596 0.7×	204 0.7×	59 0.2×	337 1.5×	353 1.7×	6	799
Julie M. Blair Australia	9	368 0.4×	260 0.9×	48 0.2×	76 0.3×	118 0.6×	12	768

Countries citing papers authored by Devchand Paul

Since Specialization

Citations

This map shows the geographic impact of Devchand Paul's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Devchand Paul with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Devchand Paul more than expected).

Fields of papers citing papers by Devchand Paul

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Devchand Paul. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Devchand Paul. The network helps show where Devchand Paul may publish in the future.

Co-authorship network of co-authors of Devchand Paul

This figure shows the co-authorship network connecting the top 25 collaborators of Devchand Paul. A scholar is included among the top collaborators of Devchand Paul based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Devchand Paul. Devchand Paul is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jones, Vicky, Kristi McIntyre, Devchand Paul, et al.. (2019). Evaluation of Miracle Mouthwash plus Hydrocortisone Versus Prednisolone Mouth Rinses as Prophylaxis for Everolimus-Associated Stomatitis: A Randomized Phase II Study. The Oncologist. 24(9). 1153–1158. 15 indexed citations

Dorn, P.L., et al.. (2018). Application of 21-gene recurrence score results and ASTRO suitability criteria in breast cancer patients treated with intraoperative radiation therapy (IORT). The American Journal of Surgery. 216(4). 689–693. 6 indexed citations

Blum, Joanne L., Patrick J. Flynn, Greg Yothers, et al.. (2016). Interim joint analysis of the ABC (anthracyclines in early breast cancer) phase III trials (USOR 06-090, NSABP B-46I/USOR 07132, NSABP B-49 [NRG Oncology]) comparing docetaxel + cyclophosphamide (TC) v anthracycline/taxane-based chemotherapy regimens (TaxAC) in women with high-risk, HER2-negative breast cancer.. Journal of Clinical Oncology. 34(15_suppl). 1000–1000. 14 indexed citations

Yardley, Denise A., James A. Reeves, Elizabeth Claire Dees, et al.. (2016). Ramucirumab With Eribulin Versus Eribulin in Locally Recurrent or Metastatic Breast Cancer Previously Treated With Anthracycline and Taxane Therapy: A Multicenter, Randomized, Phase II Study. Clinical Breast Cancer. 16(6). 471–479.e1. 29 indexed citations

O’Shaughnessy, Joyce, Hartmut Koeppen, Yuanyuan Xiao, et al.. (2015). Patients with Slowly Proliferative Early Breast Cancer Have Low Five-Year Recurrence Rates in a Phase III Adjuvant Trial of Capecitabine. Clinical Cancer Research. 21(19). 4305–4311. 37 indexed citations

Thompson, Henry J., Scot Sedlacek, Mary C. Playdon, et al.. (2015). Weight Loss Interventions for Breast Cancer Survivors: Impact of Dietary Pattern. PLoS ONE. 10(5). e0127366–e0127366. 11 indexed citations

Paul, Devchand, Scot Sedlacek, Anne Favret, et al.. (2013). Adjuvant docetaxel and cyclophosphamide plus trastuzumab in patients with HER2-amplified early stage breast cancer: a single-group, open-label, phase 2 study. The Lancet Oncology. 14(11). 1121–1128. 92 indexed citations

Thompson, Henry J., Scot Sedlacek, Devchand Paul, et al.. (2012). Effect of dietary patterns differing in carbohydrate and fat content on blood lipidand glucose profiles based on weight-loss success of breast-cancer survivors. Breast Cancer Research. 14(1). R1–R1. 20 indexed citations

Pippen, John, Devchand Paul, Svetislava J. Vukelja, Alicia Clawson, & José Iglesias. (2011). Dose-dense doxorubicin and cyclophosphamide followed by dose-dense albumin-bound paclitaxel plus bevacizumab is safe as adjuvant therapy in patients with early stage breast cancer. Breast Cancer Research and Treatment. 130(3). 825–831. 16 indexed citations

10.

Robert, Nicholas J., Mansoor N. Saleh, Devchand Paul, et al.. (2011). Sunitinib Plus Paclitaxel Versus Bevacizumab Plus Paclitaxel for First-Line Treatment of Patients With Advanced Breast Cancer: A Phase III, Randomized, Open-Label Trial. Clinical Breast Cancer. 11(2). 82–92. 94 indexed citations

11.

Pippen, John, Devchand Paul, Christopher Stokoe, et al.. (2011). Randomized, phase III study of adjuvant doxorubicin plus cyclophosphamide (AC) → docetaxel (T) with or without capecitabine (X) in high-risk early breast cancer: Exploratory Ki-67 analyses.. Journal of Clinical Oncology. 29(15_suppl). 500–500. 9 indexed citations

12.

Ellis, Georgiana K., Henry G. Bone, Rowan T. Chlebowski, et al.. (2009). Effect of denosumab on bone mineral density in women receiving adjuvant aromatase inhibitors for non-metastatic breast cancer: subgroup analyses of a phase 3 study. Breast Cancer Research and Treatment. 118(1). 81–87. 74 indexed citations

13.

Osborne, Cynthia R., Scot Sedlacek, Devchand Paul, et al.. (2009). The addition of hormone therapy to tamoxifen does not prevent hot flashes in women at high risk for developing breast cancer. Breast Cancer Research and Treatment. 116(3). 521–527. 8 indexed citations

14.

Jones, Stephen E., Ruth Oratz, Devchand Paul, et al.. (2009). Cardiac Safety Results of a Phase II Trial of Adjuvant Docetaxel/Cyclophosphamide Plus Trastuzumab (Her TC) in HER2+ Early Stage Breast Cancer Patients.. Cancer Research. 69(24_Supplement). 5082–5082. 2 indexed citations

15.

Ellis, Georgiana K., Henry G. Bone, Rowan T. Chlebowski, et al.. (2008). Randomized Trial of Denosumab in Patients Receiving Adjuvant Aromatase Inhibitors for Nonmetastatic Breast Cancer. Journal of Clinical Oncology. 26(30). 4875–4882. 342 indexed citations

16.

Jones, Stephen E., Christopher Stokoe, Mark D. Sborov, et al.. (2008). The Effect of Tamoxifen or Exemestane on Bone Mineral Density During the First 2 Years of Adjuvant Treatment of Postmenopausal Women with Early Breast Cancer. Clinical Breast Cancer. 8(6). 527–532. 20 indexed citations

17.

Carter, Dennis L., et al.. (2008). Predictors for Clinical Outcomes After Accelerated Partial Breast Intensity-Modulated Radiotherapy. International Journal of Radiation Oncology*Biology*Physics. 74(1). 92–97. 10 indexed citations

18.

Loesch, David, Lina Asmar, Kristi McIntyre, et al.. (2008). Phase II Trial of Gemcitabine/Carboplatin (plus Trastuzumab in HER2-Positive Disease) in Patients with Metastatic Breast Cancer. Clinical Breast Cancer. 8(2). 178–186. 24 indexed citations

19.

Paul, Devchand, et al.. (2002). No difference in menopausal symptoms and severity of hot flashes comparing combined hormone replacement therapy plus tamoxifen to tamoxifen alone in peri- or postmenopausal women at high risk for developing breast cancer. 1. 162. 1 indexed citations

20.

Robins, H. Ian, et al.. (1995). Cytokine induction by 41.8 °C whole body hyperthermia. Cancer Letters. 97(2). 195–201. 78 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact